Dr. Wendy Stock, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Area of expertise
Acute Lymphoblastic Leukemia
Wendy Stock, MD has run 9 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Burkitt Lymphoma
Wendy Stock, MD has run 8 trials for Burkitt Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago Comprehensive Cancer Center
University Of Chicago
Clinical Trials Wendy Stock, MD is currently running
Venetoclax + Chemotherapy
for Leukemia
This research study is studying a medication called Venetoclax and a chemotherapy regimen as a possible treatment for Acute Lymphoblastic Leukemia. The drugs involved in this study are: * Venetoclax * Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine
Recruiting
3 awards
Phase 1 & 2
Ruxolitinib + Chemotherapy
for Acute Lymphoblastic Leukemia
This study will test if adding ruxolitinib to standard multi-drug chemotherapy regimen will be safe and tolerated in adolescents and young adults with newly diagnosed Ph-like acute lymphoblastic leukemia (ALL).
Recruiting
3 awards
Phase 1
More about Wendy Stock, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Wendy Stock, MD has experience with
- Cytarabine
- Inotuzumab Ozogamicin
- Venetoclax
- Dexamethasone
- Cyclophosphamide
- Doxorubicin
Breakdown of trials Wendy Stock, MD has run
Acute Lymphoblastic Leukemia
Burkitt Lymphoma
Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Wendy Stock, MD specialize in?
Wendy Stock, MD focuses on Acute Lymphoblastic Leukemia and Burkitt Lymphoma. In particular, much of their work with Acute Lymphoblastic Leukemia has involved BCR-ABL1 positive patients, or patients who are Philadelphia chromosome negative.
Is Wendy Stock, MD currently recruiting for clinical trials?
Yes, Wendy Stock, MD is currently recruiting for 8 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Wendy Stock, MD has studied deeply?
Yes, Wendy Stock, MD has studied treatments such as Cytarabine, Inotuzumab Ozogamicin, Venetoclax.
What is the best way to schedule an appointment with Wendy Stock, MD?
Apply for one of the trials that Wendy Stock, MD is conducting.
What is the office address of Wendy Stock, MD?
The office of Wendy Stock, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.